Annual EBIT
-$7.08 M
+$3.75 M+34.62%
December 31, 2023
Summary
- As of February 12, 2025, INVO annual earnings before interest & taxes is -$7.08 million, with the most recent change of +$3.75 million (+34.62%) on December 31, 2023.
- During the last 3 years, INVO annual EBIT has fallen by -$1.57 million (-28.49%).
Performance
INVO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$1.33 M
+$547.83 K+29.21%
September 30, 2024
Summary
- As of February 12, 2025, INVO quarterly earnings before interest & taxes is -$1.33 million, with the most recent change of +$547.83 thousand (+29.21%) on September 30, 2024.
- Over the past year, INVO quarterly EBIT has increased by +$85.63 thousand (+6.06%).
Performance
INVO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$6.41 M
-$433.27 K-7.25%
September 30, 2024
Summary
- As of February 12, 2025, INVO TTM earnings before interest & taxes is -$6.41 million, with the most recent change of -$433.27 thousand (-7.25%) on September 30, 2024.
- Over the past year, INVO TTM EBIT has dropped by -$246.37 thousand (-4.00%).
Performance
INVO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
INVO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.6% | +6.1% | -4.0% |
| 3 y3 years | -28.5% | +52.1% | +2.9% |
| 5 y5 years | -168.8% | +52.1% | +2.9% |
INVO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +31.5% | +52.9% | -560.7% | +110.9% | +19.0% | +69.1% |
| 5 y | 5-year | +297.9% | +52.9% | -560.7% | +110.9% | +260.0% | +69.1% |
| alltime | all time | -2387.1% | +52.9% | -243.6% | +234.4% | -694.7% | +69.1% |
INVO Bioscience EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.33 M(-29.2%) | -$6.41 M(+7.3%) |
| Jun 2024 | - | -$1.88 M(+32.7%) | -$5.97 M(-3.0%) |
| Mar 2024 | - | -$1.41 M(-21.0%) | -$6.16 M(-13.0%) |
| Dec 2023 | -$7.08 M(-34.6%) | -$1.79 M(+100.1%) | -$7.08 M(-11.5%) |
| Sep 2023 | - | -$894.50 K(-56.6%) | -$8.00 M(-17.1%) |
| Jun 2023 | - | -$2.06 M(-11.6%) | -$9.65 M(-7.1%) |
| Mar 2023 | - | -$2.33 M(-13.8%) | -$10.39 M(-4.0%) |
| Dec 2022 | -$10.83 M(+101.1%) | -$2.71 M(+6.3%) | -$10.83 M(+38.3%) |
| Sep 2022 | - | -$2.55 M(-9.0%) | -$7.83 M(+2.1%) |
| Jun 2022 | - | -$2.80 M(+1.0%) | -$7.67 M(+16.3%) |
| Mar 2022 | - | -$2.77 M(-1062.1%) | -$6.60 M(+22.6%) |
| Dec 2021 | -$5.38 M(-2.3%) | $288.20 K(-112.1%) | -$5.38 M(-27.8%) |
| Sep 2021 | - | -$2.39 M(+38.3%) | -$7.46 M(+17.7%) |
| Jun 2021 | - | -$1.73 M(+10.8%) | -$6.34 M(+11.7%) |
| Mar 2021 | - | -$1.56 M(-12.6%) | -$5.67 M(+2.9%) |
| Dec 2020 | -$5.51 M(+209.7%) | -$1.78 M(+40.7%) | -$5.51 M(+23.6%) |
| Sep 2020 | - | -$1.27 M(+19.3%) | -$4.46 M(+16.6%) |
| Jun 2020 | - | -$1.06 M(-23.9%) | -$3.82 M(+35.3%) |
| Mar 2020 | - | -$1.40 M(+90.7%) | -$2.83 M(+58.9%) |
| Dec 2019 | -$1.78 M(-32.4%) | -$732.20 K(+15.8%) | -$1.78 M(+14.0%) |
| Sep 2019 | - | -$632.40 K(+861.1%) | -$1.56 M(+39.6%) |
| Jun 2019 | - | -$65.80 K(-81.2%) | -$1.12 M(-60.7%) |
| Mar 2019 | - | -$349.10 K(-32.0%) | -$2.84 M(+7.9%) |
| Dec 2018 | -$2.63 M(+286.6%) | -$513.40 K(+170.4%) | -$2.63 M(+13.7%) |
| Sep 2018 | - | -$189.90 K(-89.4%) | -$2.32 M(+2.0%) |
| Jun 2018 | - | -$1.79 M(+1176.1%) | -$2.27 M(+270.0%) |
| Mar 2018 | - | -$140.30 K(-28.8%) | -$614.00 K(-9.9%) |
| Dec 2017 | -$681.30 K(-67.7%) | -$197.00 K(+36.5%) | -$681.30 K(-9.7%) |
| Sep 2017 | - | -$144.30 K(+9.0%) | -$754.60 K(-7.7%) |
| Jun 2017 | - | -$132.40 K(-36.2%) | -$817.70 K(-61.7%) |
| Mar 2017 | - | -$207.60 K(-23.2%) | -$2.14 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$2.11 M(-57.2%) | -$270.30 K(+30.3%) | -$2.11 M(+1.6%) |
| Sep 2016 | - | -$207.40 K(-85.7%) | -$2.08 M(+4.5%) |
| Jun 2016 | - | -$1.45 M(+703.6%) | -$1.99 M(-60.0%) |
| Mar 2016 | - | -$180.70 K(-23.8%) | -$4.98 M(+1.0%) |
| Dec 2015 | -$4.93 M(+193.2%) | -$237.00 K(+99.5%) | -$4.93 M(+5.1%) |
| Sep 2015 | - | -$118.80 K(-97.3%) | -$4.69 M(+2.6%) |
| Jun 2015 | - | -$4.44 M(+3268.4%) | -$4.57 M(+3368.4%) |
| Mar 2015 | - | -$131.80 K(-33.9%) | -$131.80 K(-79.5%) |
| Dec 2014 | -$1.68 M(+137.1%) | - | - |
| Dec 2013 | -$708.80 K(+23.6%) | - | - |
| Dec 2012 | -$573.50 K(-10.6%) | - | - |
| Dec 2011 | -$641.80 K(-307.3%) | -$199.30 K(+179.1%) | -$642.10 K(-6.1%) |
| Sep 2011 | - | -$71.40 K(-64.6%) | -$683.50 K(-12.3%) |
| Jun 2011 | - | -$201.50 K(+18.6%) | -$779.70 K(+15.2%) |
| Mar 2011 | - | -$169.90 K(-29.4%) | -$676.60 K(-261.8%) |
| Dec 2010 | $309.60 K(-123.2%) | -$240.70 K(+43.6%) | $418.10 K(-61.2%) |
| Sep 2010 | - | -$167.60 K(+70.3%) | $1.08 M(+88.9%) |
| Jun 2010 | - | -$98.40 K(-110.6%) | $570.40 K(+142.5%) |
| Mar 2010 | - | $924.80 K(+121.0%) | $235.20 K(-117.6%) |
| Dec 2009 | -$1.34 M(-28.3%) | $418.50 K(-162.0%) | -$1.34 M(-62.6%) |
| Sep 2009 | - | -$674.50 K(+55.6%) | -$3.57 M(+22.7%) |
| Jun 2009 | - | -$433.60 K(-32.8%) | -$2.91 M(+5.8%) |
| Mar 2009 | - | -$645.70 K(-64.5%) | -$2.75 M(+29.5%) |
| Dec 2008 | -$1.86 M(+4179.3%) | -$1.82 M(>+9900.0%) | -$2.13 M(+554.9%) |
| Sep 2008 | - | -$13.20 K(-95.2%) | -$324.60 K(+1.7%) |
| Jun 2008 | - | -$274.00 K(+1439.3%) | -$319.10 K(+449.2%) |
| Mar 2008 | - | -$17.80 K(-9.2%) | -$58.10 K(+33.6%) |
| Dec 2007 | -$43.50 K(+472.4%) | -$19.60 K(+154.5%) | -$43.50 K(+82.0%) |
| Sep 2007 | - | -$7700.00(-40.8%) | -$23.90 K(+47.5%) |
| Jun 2007 | - | -$13.00 K(+306.3%) | -$16.20 K(+406.3%) |
| Mar 2007 | - | -$3200.00 | -$3200.00 |
| Dec 2006 | -$7600.00 | - | - |
FAQ
- What is INVO Bioscience annual earnings before interest & taxes?
- What is the all time high annual EBIT for INVO Bioscience?
- What is INVO Bioscience annual EBIT year-on-year change?
- What is INVO Bioscience quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for INVO Bioscience?
- What is INVO Bioscience quarterly EBIT year-on-year change?
- What is INVO Bioscience TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for INVO Bioscience?
- What is INVO Bioscience TTM EBIT year-on-year change?
What is INVO Bioscience annual earnings before interest & taxes?
The current annual EBIT of INVO is -$7.08 M
What is the all time high annual EBIT for INVO Bioscience?
INVO Bioscience all-time high annual earnings before interest & taxes is $309.60 K
What is INVO Bioscience annual EBIT year-on-year change?
Over the past year, INVO annual earnings before interest & taxes has changed by +$3.75 M (+34.62%)
What is INVO Bioscience quarterly earnings before interest & taxes?
The current quarterly EBIT of INVO is -$1.33 M
What is the all time high quarterly EBIT for INVO Bioscience?
INVO Bioscience all-time high quarterly earnings before interest & taxes is $924.80 K
What is INVO Bioscience quarterly EBIT year-on-year change?
Over the past year, INVO quarterly earnings before interest & taxes has changed by +$85.63 K (+6.06%)
What is INVO Bioscience TTM earnings before interest & taxes?
The current TTM EBIT of INVO is -$6.41 M
What is the all time high TTM EBIT for INVO Bioscience?
INVO Bioscience all-time high TTM earnings before interest & taxes is $1.08 M
What is INVO Bioscience TTM EBIT year-on-year change?
Over the past year, INVO TTM earnings before interest & taxes has changed by -$246.37 K (-4.00%)